Investigating the Role of Anti- Angiogenic Agents in Ovarian Cancer Carol Aghajanian, M.D. Chief, Gynecologic Medical Oncology Memorial Sloan-Kettering.
Making Sense of What we Read about Scleroderma Treatments
Making Sense of What we Read about Scleroderma Treatments Kimberly Watkinson September 19, 2014.
